ONCE, NTLA REGN Stocks

These stocks have had an upward trend for the last few days making 3%-5%. That’s a pretty good figure in the stock world. Now the reason for this is that ONCE (company that founded Luxturna) has had their product approved by FDA not too long ago. This companies has said to have found the cure for blindness in some people. I’m not surprised that it only has risen 4.7%, if the price of it was cheaper I think this stock could be worth a lot more. But with a price tag of $425k, who really is going to get this done. But they use a good concept, gene editing. Gene editing has been the talk of some stock advisors and I think it will really take off in the next couple years. But for now these stocks that have invested greatly in gene editing or have their own research and products will slowly rise. I personally have invested in ONCE and hey 4.7% is definitely something. Nothing compared to my crypto returns but this is good enough. ONCE, NTLA and REGN are the main players in the gene editing world right now so if you want a safe bet in stocks these will Be it.